InvestorsHub Logo
Followers 16
Posts 1544
Boards Moderated 0
Alias Born 06/11/2010

Re: Alyssa post# 53477

Wednesday, 08/16/2017 10:03:35 AM

Wednesday, August 16, 2017 10:03:35 AM

Post# of 205097
Not intending to start a debate here. Just stating my opinions.

1. All paid promotions are suspect in my opinion. Have you ever seen one that wasn't positive?

2. When this piece was written there were 30mm shares outstanding, not 1 billion.

3. Much of the value that they placed on the stock was predicated on OvaDX approval - OvaDX is no where near FDA submission. Technically Arrayit doesn't even own the IP anymore - Avant does.

4. There is a lot that COULD happen but I don't see the company doubling or tripling sales any time soon (basing this on an expected $6-$10mm revenue figure for 2016/2017). By the company's own admission, their growth mirrors Illumina's which was in the 10% range.